A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #21 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, JNJ claims the #314 spot.
Below is a chart of rank over time:
JNJ operates in the Drugs & Pharmaceuticals sector, among companies like Novo-Nordisk AS (NVO) which is down about 0.8% today, and Eli Lilly (LLY) trading lower by about 0.5%. Below is a three month price history chart comparing the stock performance of JNJ, versus NVO and LLY.
JNJ is currently trading up about 1.4% midday Wednesday.
The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks »
Also see:
Institutional Holders of ATEK
DWAS Historical Stock Prices
KREF Next Dividend Date
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
